Below is the 2020 schedule and agenda for the BIO CEO & Investor Conference. For the latest program updates, additions and cancellations to the printed program, click here

BIO CEO & Investor Digital Conference
Date
  • Show All
Time
  • Show All
Company Type
  • Show All
Main Therapeutic Focus
  • Show All
Development Phase of Primary Product
  • Show All
Search Sessions
BIO CEO & Investor Digital Conference
Jump to Day
  • Show All
Tuesday, February 16
9:00 AM - 5:00 PM (EST)
Meet with other attendees via the partnering system.
10:00 AM - 1:00 PM (EST)
Both days will feature excellent, curated content including Fireside Chats and Panels on a range of…
1:00 PM - 2:00 PM (EST)
Join other attendees for virtual, face to face networking.
2:00 PM - 5:00 PM (EST)
Both days will feature excellent, curated content including Fireside Chats and Panels on a range of…
Wednesday, February 17
9:00 AM - 5:00 PM (EST)
Meet with other attendees via the partnering system.
10:00 AM - 1:00 PM (EST)
Both days will feature excellent, curated content including Fireside Chats and Panels on a range of…
1:00 PM - 2:00 PM (EST)
Join other attendees for virtual, face to face networking.
2:00 PM - 5:00 PM (EST)
Both days will feature excellent, curated content including Fireside Chats and Panels on a range of…
Available On-Demand
9 Meters Biopharma (the “Company”) is focused on developing therapies for gastrointestinal (GI)…
AGT, has a broad viral vector delivery platform evolved over ten years of advanced development. AGT…
Annovis Bio, Inc. is a clinical-stage, drug platform company addressing neurodegeneration, such as…
Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP) is a biopharmaceutical company…
Elevation Oncology is founded on the belief that every patient with cancer deserves to know what is…
Greenwich LifeSciences (Nasdaq: GLSI) is a public biopharmaceutical company located in Houston, TX…
Helixmith Co., Ltd is a gene therapy company with over 20 years experience developing new and…
Morphogenesis is a clinical stage cell/gene therapy company focusing on a platform of cancer…
Most drug candidates (>70%) are poorly soluble resulting in poor bioavailability. Many…
Newron is a biopharmaceutical company focused on the development of novel therapies for patients…
Novome Biotechnologies is a biotechnology company focused on engineering defined activities into…
Primary Peptides Inc is a clinical-stage biotech company. We are developing novel peptide…
Protalix is a biopharmaceutical company focused on the development and commercialization of…
Saniona is a biopharmaceutical company focused on discovering, developing, and delivering…
Tonix is a clinical-stage biopharmaceutical company focused on discovering, licensing, acquiring…
Vyriad is a clinical-stage company developing proprietary oncolytic virus therapies for the…